How Much Can You Save?
Speak With a Copay Assistance Specialist
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances.
Get Started in Minutes
How Zejula Copay Assistance Works
1 – Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
2 – Transfer Prescription to AmeriPharma
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
3 – Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
4 – Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.
5 – Nursing Care Coordination
AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
6 – Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
Speak With a Specialist
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
What Is Zejula?
Zejula (niraparib) is an oral targeted therapy medication used for the treatment of ovarian, fallopian tube, and primary peritoneal cancer. Zejula is a PARP (poly adenosine diphosphate-ribose polymerase) inhibitor that specifically targets cancer cells and exerts less harm on healthy cells in the body. PARP is a protein found in human cells which aids in repairing damaged cells. PARP inhibitors as targeted treatments work by blocking the repair of cancerous cells and allowing them to die.
PARP inhibitors are given to patients after full or partial response to initial chemotherapy with a platinum-based medication. Zejula is used as a maintenance treatment to help prevent cancer from coming back. Zejula is a once-daily oral maintenance medication treatment available in 100 mg capsules that can be taken with or without food.
Schedule a Consultation
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
What is Zejula Used to Treat?
Zejula is FDA approved for adult patients as a maintenance treatment for recurrent maintenance therapy. It is approved for women with advanced ovarian cancer in complete or partial response, such as advanced or recurrent:
- Epithelial ovarian cancer
- Fallopian tube cancer
- Primary peritoneal cancer
Zejula is also used for the treatment of adult patients who have been treated with three or more prior chemotherapy regimens associated with homologous recombination deficiency (HRD) positive status defined by either:
- A harmful or suspected-to-be-harmful BRCA mutation, or
- A genomic instability that progressed more than 6 months after response to the last chemotherapy session.
Copay and Financial Assistance
AmeriPharma Specialty Care alleviates financial burdens for patients and their families
Advanced software locates funding sources to match you with top-dollar foundation programs
One of our copay assistance specialists will assist with the application process
Automatic updates will be sent to you and your physician on the status of the funding
Speak With a Specialist
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Zejula Side Effects
Common side effects include:
- Mouth sores
- Stomach pain
- Constipation or diarrhea
- Loss of appetite
- Urinary tract infections
- Heartburn or indigestion
- Anxiety
- Sore throat
- Shortness of breath
- Rash
Other side effects of Zejula include:
- Musculoskeletal pain
- Abdominal pain
- Cough
- Insomnia
Serious side effects include:
- Bone marrow suppression: Complete blood counts should be monitored weekly for the first month. Patients should inform their prescribers if any of these symptoms occur:
- Weakness
- Feeling tired
- Fever
- Frequent infections
- More bruising or bleeding more easily
- Blood in urine
- Cardiovascular effects: Blood pressure and heart rate should be monitored at least weekly for the first two months. Patients should inform their prescribers if any of these symptoms occur:
-
- Irregular heartbeat
- Hypertension
- Cough
- Dizziness
- Nausea
Schedule a Consultation
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Zejula Dosing Information
Zejula is only available in 100 mg capsules, and the recommended dosages are shown below:
- First-line Maintenance Treatment for Advanced Ovarian Cancer
- For patients who weigh < 77 kg (<170 lbs) OR with a platelet count <150,000/ μL, the recommended dose is 200 mg taken by mouth once a day.
- For patients who weigh >77 kg (>170 lbs) OR with a platelet count >150.000/ μL, the recommended dose is 300 mg taken by mouth once a day.
- Maintenance Treatment for Recurrent Ovarian Cancer
- The recommended dose is 300 mg (3 capsules) taken orally once daily.
- Treatment of Advanced Ovarian Cancer After Three or More Chemotherapy Regimens
- The recommended dose is 300 mg (3 capsules) taken orally once daily.
Zejula can be taken with or without food. Take the medication at approximately the same time each day. Taking the medication at bedtime may help relieve symptoms of nausea.
Treatment with Zejula will require routine monitoring of blood pressure, heart rate, and blood cell count.
Continue Zeluja treatment until disease progression or unacceptable toxicity.
It is not known if Zejula is safe and effective in children.
Zejula can cause fetal harm if administered to pregnant patients. Avoid breastfeeding and use effective contraceptives during treatment and for 6 months after the last dose of Zeluja. If you get pregnant, contact your doctor immediately.